R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm (Q39550565)
Jump to navigation
Jump to search
scientific article published on 29 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm |
scientific article published on 29 April 2011 |
Statements
1 reference
R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm (English)
1 reference
Kotaro Shide
1 reference
Takuro Kameda
1 reference
Vadim Markovtsov
1 reference
Haruko K Shimoda
1 reference
Elizabeth Tonkin
1 reference
Shuling Fang
1 reference
Chian Liu
1 reference
Marina Gelman
1 reference
Wayne Lang
1 reference
Jason Romero
1 reference
John McLaughlin
1 reference
Somasekhar Bhamidipati
1 reference
Jeffrey Clough
1 reference
Caroline Low
1 reference
Andrea Reitsma
1 reference
Stacey Siu
1 reference
Polly Pine
1 reference
Gary Park
1 reference
Allan Torneros
1 reference
Matt Duan
1 reference
Rajinder Singh
1 reference
Donald G Payan
1 reference
Takuya Matsunaga
1 reference
Yasumichi Hitoshi
1 reference
Kazuya Shimoda
1 reference
29 April 2011
1 reference
1 reference
117
1 reference
25
1 reference
6866-6875
1 reference
Identifiers
1 reference
1 reference